Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,013 | 315 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,347 | 65 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,557 | 58 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,047 | 18 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $911.17 | 28 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $706.82 | 19 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $505.93 | 20 | $0 (2021) |
| AbbVie Inc. | $493.86 | 8 | $0 (2021) |
| Merck Sharp & Dohme LLC | $454.67 | 20 | $0 (2023) |
| Amarin Pharma Inc. | $399.74 | 10 | $0 (2022) |
| GlaxoSmithKline, LLC. | $356.55 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $270.62 | 3 | AstraZeneca Pharmaceuticals LP ($270.62) |
| 2023 | $1,754 | 45 | AstraZeneca Pharmaceuticals LP ($535.37) |
| 2022 | $2,298 | 51 | AstraZeneca Pharmaceuticals LP ($690.29) |
| 2021 | $1,488 | 39 | AstraZeneca Pharmaceuticals LP ($560.75) |
| 2020 | $1,592 | 46 | AstraZeneca Pharmaceuticals LP ($486.75) |
| 2019 | $1,928 | 47 | AstraZeneca Pharmaceuticals LP ($495.75) |
| 2018 | $895.28 | 34 | Regeneron Healthcare Solutions, Inc. ($196.68) |
| 2017 | $1,787 | 50 | Novartis Pharmaceuticals Corporation ($600.86) |
All Payment Transactions
315 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2023 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Genetic Disease | ||||||
| 12/06/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 12/04/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.92 | General |
| Category: Cardiovascular | ||||||
| 11/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 10/16/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: Cardiovascular | ||||||
| 10/05/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $20.82 | General |
| Category: Not Applicable | ||||||
| 09/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/03/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/21/2023 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Transcatheter Heart Valves | ||||||
| 07/14/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 07/13/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 07/10/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: DIABETES | ||||||
| 06/22/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/08/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 06/06/2023 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Genetic Disease | ||||||
| 06/02/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Cardiology | ||||||
About Dr. Rosa Carrera, MD
Dr. Rosa Carrera, MD is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780617407.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rosa Carrera, MD has received a total of $12,013 in payments from pharmaceutical and medical device companies, with $270.62 received in 2024. These payments were reported across 315 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($12,013).
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 07/08/2006
- Last Updated 10/24/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780617407
Products in Payments
- FARXIGA (Drug) $1,778
- ELIQUIS (Drug) $1,252
- ENTRESTO (Drug) $911.17
- JARDIANCE (Drug) $774.69
- BRILINTA (Drug) $734.70
- LOKELMA (Drug) $496.01
- VERQUVO (Drug) $454.67
- Vascepa (Drug) $399.74
- PRALUENT ALIROCUMAB INJECTION (Biological) $395.38
- XARELTO (Drug) $369.86
- Creon (Drug) $325.59
- PRALUENT (Biological) $311.44
- WATCHMAN (Device) $308.95
- CAMZYOS (Drug) $283.18
- NURTEC ODT (Drug) $266.60
- TRELEGY ELLIPTA (Drug) $231.55
- LifeVest (Device) $199.63
- YOSPRALA (Drug) $178.88
- PRADAXA (Drug) $178.68
- ZONTIVITY (Drug) $170.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799